Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01812824 · ClinicalTrials.gov registry record · NA

Study of Virtual Patient Advocate for Preconception Care for African American Women

A NA study, sponsored by Boston Medical Center.

Completed
Registry status
NA
Development phase
100
Enrollment target

NCT01812824 is a NA study that has completed, run by Boston Medical Center. The registered enrollment target is 100 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01812824, a NA study, has completed, sponsored by Boston Medical Center.

COMPLETED
Registry status
NA
Development phase
100 participants
Enrollment target

Study Summary

This study is to examine the effectiveness of a health communication system (Gabby) that assesses preconception health risks and tailors the intervention to each subject, based on her health risks. There is a need to develop practical tools that can be used to identify preconception health risks and will facilitate the initiation of intervention for these risks; this project specifically targets young Black or African American women in order to reduce major disparities in birth outcomes. Clinicians do not have time to assess for over 100 preconception health risks that can impact birth outcomes; this system can streamline that assessment and create a personalized list of risks. Patients can then share their list with clinicians to make their healthcare visits more effective. This study involves a pilot of the system through the Preconception Peer Educator (PPE) Program, which is a program created by the Office of Minority Health. The program began in historically black colleges in the United States, with the purpose of training students to reach out to their community to educate about the increased risk of preterm birth, low birth weight and infant mortality among African Americans. The PPEs teach about preconception health, or getting healthy before pregnancy, to increase the chances of having a healthy baby. Now the PPE program has expanded to colleges in over 20 states across the country.

Interventions

  • BEHAVIORAL Intervention (Virtual Patient Advocate)

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2011-02
Est. Completion 2015-01
Phase NA

Sponsor

Boston Medical Center

253 total trials

What the Registry Record Tells You About NCT01812824

The ClinicalTrials.gov registry entry for NCT01812824 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Medical Center, which has 253 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Intervention (Virtual Patient Advocate) is the first listed.

NCT01812824 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01812824 about?

NCT01812824 is a clinical study titled "Study of Virtual Patient Advocate for Preconception Care for African American Women". This study is to examine the effectiveness of a health communication system (Gabby) that assesses preconception health risks and tailors the intervention to each subject, based on her health risks. There is a need to develop practical tools that can be used to identify preconception health risks an...

What is the current status of trial NCT01812824?

This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2011-02. Estimated completion is 2015-01.

What interventions are being tested in trial NCT01812824?

The interventions under investigation include: Intervention (Virtual Patient Advocate) (BEHAVIORAL).

Who is sponsoring clinical trial NCT01812824?

This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.